Editorial & Opinion

Rituximab desensitization protocol in a child with secondary lymphoproliferative disease.

التفاصيل البيبلوغرافية
العنوان: Rituximab desensitization protocol in a child with secondary lymphoproliferative disease.
المؤلفون: Aranda CS; Federal University, São Paulo, Brazil. Electronic address: carolaaranda@yahoo.com.br., Ensina LF; Federal University, São Paulo, Brazil., Mallozi MC; Federal University, São Paulo, Brazil., Filho VO; University of São Paulo, São Paulo, Brazil., Solé D; Federal University, São Paulo, Brazil.
المصدر: Annals of allergy, asthma & immunology : official publication of the American College of Allergy, Asthma, & Immunology [Ann Allergy Asthma Immunol] 2019 Nov; Vol. 123 (5), pp. 526.
نوع المنشور: Letter; Comment
اللغة: English
بيانات الدورية: Publisher: American College of Allergy, Asthma, and Immunology Country of Publication: United States NLM ID: 9503580 Publication Model: Print Cited Medium: Internet ISSN: 1534-4436 (Electronic) Linking ISSN: 10811206 NLM ISO Abbreviation: Ann Allergy Asthma Immunol Subsets: MEDLINE
أسماء مطبوعة: Original Publication: McLean, VA : American College of Allergy, Asthma, and Immunology
مواضيع طبية MeSH: Connective Tissue Diseases* , Lymphoproliferative Disorders* , Neoplasms*, Child ; Desensitization, Immunologic ; Humans ; Rituximab
التعليقات: Comment on: Ann Allergy Asthma Immunol. 2019 Jul;123(1):11-15. (PMID: 30885801)
المشرفين على المادة: 4F4X42SYQ6 (Rituximab)
تواريخ الأحداث: Date Created: 20191103 Date Completed: 20200302 Latest Revision: 20200302
رمز التحديث: 20231215
DOI: 10.1016/j.anai.2019.09.004
PMID: 31676020
قاعدة البيانات: MEDLINE
الوصف
تدمد:1534-4436
DOI:10.1016/j.anai.2019.09.004